Cartilage Repair/ Cartilage Regeneration Market Worth 779.8 Million USD by 2021

Friday 9 December 2016, Amsterdam

Market Research Report Press Release The report, now available on ASDReports, "Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - Forecast to 2021", The cartilage repair/ cartilage regeneration market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.

Increase in obese population and rising incidence of sports injuries are the major factors driving the demand of cartilage repair/ cartilage regeneration. On the other hand, high cost of therapy and unfavorable reimbursement scenario are the major factors restraining the growth of this market.

The cartilage repair/ cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share in 2016.This treatment modality segment is also expected to be the fastest growing segment in the cartilage repair/ cartilage regeneration market. This segment is projected to grow at CAGR of 14.1% during forecast period. The large share and high growth of this segment can be attributed to long-term results of these therapies in terms of cartilage repair which makes it most preferred therapy.

On the basis of applications, the cartilage repair/ cartilage regeneration market is segmented into hyaline cartilage and fibrocartilage. Among this segments, the hyaline cartilage segment is expected to account for the largest market share in 2016. Hyaline cartilage application segment is also expected to be the fastest growing application segment in the cartilage repair/ cartilage regeneration market. This application segment is projected to grow at CAGR of 13.9% during forecast period. The large share and high growth of this segment can be attributed to the high prevalence of cartilage damage in hyaline cartilage.

Globally, North America is expected to be the fastest-growing regional segment in the cartilage repair/ cartilage regeneration market. North America is also expected to account for largest share in the cartilage repair/ cartilage regeneration market, by region in 2016. The high growth and largest share of this segment can primarily be attributed to the expansion of the cartilage repair/ cartilage regeneration market in this region due to presence of major players in this market and wide availability of cartilage repair products.

The major players operating in the cartilage repair/ cartilage regeneration market include Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).
Cartilage Repair/ Cartilage Regeneration Market - Forecast to 2021

Cartilage Repair/ Cartilage Regeneration Market - Forecast to 2021

Publish date : December 2016
Report code : ASDR-313807
Pages : 102

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News